REGENXBIO Inc.
RGNX
$9.66
$0.293.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 125.22% | -34.11% | -8.41% | 12.60% | -1,265.07% |
| Total Depreciation and Amortization | -2.59% | -0.31% | -0.44% | -0.49% | -1.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.65% | -10.00% | 2.59% | 23.60% | 40.49% |
| Change in Net Operating Assets | -6,776.23% | 16.51% | 82.65% | -237.58% | -54.07% |
| Cash from Operations | 18.31% | -45.70% | 6.56% | -13.41% | -246.72% |
| Capital Expenditure | 38.46% | -143.11% | -3.46% | -25.58% | 61.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.15% | 88.78% | -11.06% | 130.55% | -406.00% |
| Cash from Investing | -6.61% | 88.04% | -11.23% | 130.11% | -413.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,362.22% | 782.22% | -87.85% | 850.00% | -82.93% |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.45% | -40.63% | -25.62% | -105.53% | 2,523.86% |
| Cash from Financing | 228.83% | -42.31% | -35.31% | -105.09% | 2,503.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 210.51% | 20.95% | -17.25% | 58.94% | -169.64% |